我国首个泛癌基因变异图谱公布

Core Insights - The Chinese Academy of Medical Sciences Cancer Hospital has established the first large-scale pan-cancer real-world genomic database in China, revealing differences in genetic variation characteristics between Chinese and Western cancer patients, which is crucial for precision cancer treatment and clinical trial design [1][2] Group 1: Database Establishment - The research team, led by Professors Li Wenbin and Ying Jianming, collected samples from nearly 7,000 patients who underwent genetic sequencing, covering 54 common types of tumors [1] - The database addresses the long-standing lack of genomic data for Asian populations, particularly in China, which has hindered the applicability of existing international treatment standards for Chinese patients [1] Group 2: Research Findings - The study found that four types of gene mutations have the highest frequency among Chinese patients, with one gene inactivation mutation occurring in over 80% of cases in esophageal squamous cell carcinoma, small cell lung cancer, and lung squamous cell carcinoma [2] - Specific gene mutation rates in Chinese lung adenocarcinoma patients were significantly higher than those in Western populations, filling a critical gap in the understanding of pan-cancer genomic characteristics in China [2] Group 3: Future Implications - As clinical follow-up data continues to improve, the database is expected to provide deeper insights into the relationship between tumor molecular characteristics, treatment efficacy, and patient prognosis, supporting precision prevention, diagnosis, and treatment of cancer [2]